Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Lymphocytic Vasculitis of the Central Nervous System

Gbemisola Olayemi, MD, Evangeline Scopelitis, MD, & Jerald M. Zakem, MD  |  Issue: January 2019  |  January 17, 2019

Figure 3 and Figure 4

Figure 3 and Figure 4
An interventional radiology angiogram shows multifocal areas of distal intracranial artery narrowing.

Her rheumatoid factor was 22 IU/mL (normal: 0.0–15.0 IU/mL). Her C4 was elevated at 61 mg/dL (normal: 11–44 mg/dL). Her protein/creatinine ratio was 11.07 mg/mmol (normal: 0.00–0.20 mg/mmol).

Several diseases can mimic PACNS, including reversible cerebral vasoconstriction syndrome, premature intracranial atherosclerosis, fibromuscular dysplasia, secondary cerebral vasculitis, malignancy, infections …

Her renal function worsened after the angiogram, and she eventually required dialysis. A nephrologist was consulted and attributed her proteinuria and worsened renal dysfunction to underlying diabetes and contrast-induced nephropathy. A renal ultrasound was unremarkable.

The patient was initially started on 70 mg of prednisone daily. She was switched to pulse-dose steroids (1,000 mg methyl­prednisolone daily for three days) due to worsening neurologic status. Despite the pulse-dose steroids, the patient’s clinical progression continued to worsen. Repeat imaging showed evolving subacute infarcts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

After the patient was cleared by an infectious disease specialist and after discussion with the neurologist, the decision was made to administer renally dosed cyclophosphamide (415 mg/m2).

About one week after the cyclo­phosphamide infusion, the patient was able to follow commands and was attempting to state her name. She self-extubated and had an improved GCS of 15.

A brain biopsy showed lymphocytic vasculitis of uncertain etiology and remote cortical microinfarcts, with the affected
vessels showing a modest number of intramural lymphocytes and foci of chronic inflammatory cells within the adventitia, which were primarily positive for CD3 (see Figures 5–10, right). There was no evidence of granulomatous inflammation, fibrinoid necrosis of the vessel walls or infectious organisms. The patient was tapered to 15 mg methylprednisolone for eight days and eventually discharged to an inpatient rehab facility for follow-up with the rheumatologist, neurologist and nephrologist.

The leptomenigeal artery has significant narrowing due to cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

Figure 5: The leptomenigeal artery has significant narrowing due to cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

The image at higher magnification is highlighted to show the cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

Figure 6: The image at higher magnification is highlighted to show the cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

The image at even higher magnification shows the cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

Figure 7: The image at even higher magnification shows the cholesterol accumulation, and intramural and perivascular inflammatory infiltrates.

Figure 9: Subacute cortical microinfarct displaying loss of parenchyma and reactive gliosis.

Figure 9: Subacute cortical microinfarct displaying loss of parenchyma and reactive gliosis.

Figure 8: Immunostaining for CD3 highlights the inflammatory T cell population permeating the vascular wall. CD20 was mostly negative.

Figure 8: Immunostaining for CD3 highlights the inflammatory T cell population permeating the vascular wall. CD20 was mostly negative.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:central nervous system vasculitiscyclophosphamideMethylprednisolonePrimary Angiitis of the Central Nervous System

Related Articles

    Meet the Challenge of Primary CNS Vasculitis

    September 1, 2011

    Diagnosis and treatment of this rare and poorly understood condition

    Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

    November 16, 2015

    Case report: A 60-year-old Hispanic male with poorly controlled hypertension was sent from the primary care clinic for evaluation of malignant hypertension with a systolic blood pressure above 200 mmHg. His symptoms at the time of presentation included episodic confusion, worsening vision and an unsteady gait. A head computed tomography (CT) scan showed a subacute…

    7 Key Insights Into the Evaluation of Central Nervous System Vasculitis

    May 13, 2021

    Many a rheumatology consult has centered on a perplexing question: Does this patient have central nervous system (CNS) vasculitis? At the 2021 ACR State-of-the-Art Clinical Symposium, Rula Hajj-Ali, MD, FACP, professor of medicine and associate director of vasculitis care and research, Cleveland Clinic Lerner College of Medicine, discussed this topic in detail, providing a series…

    2014 ACR/ARHP Annual Meeting: Diagnosing PACNS and Its Mimics

    February 1, 2015

    Accurate diagnosis for primary angiitis of the central nervous system requires close scrutiny, team effort

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences